Stay updated on RC48-ADC in HER2+ Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the RC48-ADC in HER2+ Urothelial Cancer Clinical Trial page.

Latest updates to the RC48-ADC in HER2+ Urothelial Cancer Clinical Trial page
- Check2 days agoChange DetectedA banner was added announcing an NIH website transition and related terminology guidance, and the displayed site revision changed from v3.7.1 to v3.7.2. The page itself remains a 403 Forbidden error.SummaryDifference1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe footer's ClinicalTrials.gov revision identifier was updated from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check30 days agoChange DetectedThe page displays a 403 Forbidden message with basic navigation, replacing the usual study details and related links.SummaryDifference17%

- Check37 days agoChange DetectedRevision: v3.7.0 is now displayed on the page, replacing the prior Revision: v3.6.6 and indicating an updated page version. The update is an administrative version change and does not modify the study details presented.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page's site revision tag was updated from v3.6.5 to v3.6.6, indicating a new build of the ClinicalTrials.gov interface. No study content or data appears to be altered by this update.SummaryDifference0.1%

- Check73 days agoChange DetectedFooter now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4, indicating a minor platform update to the page template.SummaryDifference0.1%

Stay in the know with updates to RC48-ADC in HER2+ Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RC48-ADC in HER2+ Urothelial Cancer Clinical Trial page.